Treatment with ipilimumab, cyclophosphamide/GVAX/degarelix, or degarelix alone may increase PD-L1 expression; conversely, other studies found that neoadjuvant androgen deprivation therapy may reduce PD-L1 expression by PC tumor cells. This evidence concerns the gene CD274 and neoplasm.